Literature DB >> 7357203

A comparison of rates of depletion and recovery of noradrenaline stores of peripheral and central noradrenergic neurones after reserpine administration: importance of neuronal activity.

A R Wakade.   

Abstract

1 The noradrenaline (NA) content of various peripheral sympathetic neuroeffector organs and brain was measured at various times after different doses of reserpine administered to the rat.2 About a 25% reduction in the NA content of the heart was observed 24 h after 0.005 mg/kg reserpine. Two to ten times more reserpine was needed to obtain an approximately similar degree of depletion in the salivary gland and vas deferens; 0.1 mg/kg produced almost complete depletion in the heart and salivary gland, whereas 5 mg/kg was needed to deplete the vas deferens of its NA content.3 The NA content of the brain and superior cervical ganglion was lowered by 20 to 30% in 24 h only when the reserpine dose was raised to 0.1 mg/kg, and 5 to 10 mg/kg was required to obtain over 95% depletion.4 The rates of recovery of cardiac and salivary gland NA stores, after about 80 to 100% depletion by low and high doses of reserpine, were almost identical. About 50% restoration occurred in 7 to 15 days after a single dose of 0.1 mg/kg reserpine.5 The superior cervical ganglion, the NA content of which was fully depleted by 10 mg/kg, showed almost complete recovery in about 7 days.6 Transmural stimulation of the left atrium of the guinea-pig for 30 min (5 Hz for 30 s/min), or exposure of the atrium to reserpine (5 mug/ml) for 30 min, caused modest but statistically insignificant reduction in tissue NA content. However, stimulation in the presence of reserpine 5 mug/ml for 30 min produced about 50% depletion of NA.7In vitro reduction in NA content caused by reserpine plus transmural stimulation, was even more pronounced after treatment of the isolated vas deferens of the rat with tetraethylammonium.8 It is suggested that different rates of depletion following in vivo administration of reserpine are mainly due to variation in neuronal activity of different sympathetic neuroeffector organs.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7357203      PMCID: PMC2044147          DOI: 10.1111/j.1476-5381.1980.tb10703.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  9 in total

1.  Depletion and recovery of catecholamines in the rat adrenal medulla and its relationship with dopamine beta-hydroxylase.

Authors:  W R Dixon; A G Garcia; S M Kirpekar
Journal:  Proc R Soc Lond B Biol Sci       Date:  1976-10-29

2.  Cellular localization of brain monoamines.

Authors:  A CARLSSON; B FALCK; N A HILLARP
Journal:  Acta Physiol Scand Suppl       Date:  1962

3.  SITE OF ACTION OF RESERPINE.

Authors:  A DAHLSTROEM; K FUXE; N A HILLARP
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1965

4.  Effect of decentralization and ganglionic blocking agents on the spontaneous release of H3-norepinephrine.

Authors:  G HERTTING; L T POTTER; J AXELROD
Journal:  J Pharmacol Exp Ther       Date:  1962-06       Impact factor: 4.030

5.  Further studies on the nature of persistent reserpine binding: evidence for reversible and irreversible binding.

Authors:  S Norn; P A Shore
Journal:  Biochem Pharmacol       Date:  1971-06       Impact factor: 5.858

6.  Metabolic requirements for the uptake and storage of norepinephrine by the isolated left atrium of the guinea pig.

Authors:  A R Wakade; R F Furchgott
Journal:  J Pharmacol Exp Ther       Date:  1968-09       Impact factor: 4.030

7.  Studies on the transport and life-span of amine storage granules in a peripheral adrenergic neuron system.

Authors:  A Dahlström; J Häggendal
Journal:  Acta Physiol Scand       Date:  1966 Jul-Aug

8.  The effect of pithing and of nerve stimulation on the depletion of noradrenaline by reserpine in the rat anococcygeus muscle and vas deferens.

Authors:  J S Gillespie; J C McGrath
Journal:  Br J Pharmacol       Date:  1974-12       Impact factor: 8.739

9.  The influence of pentolonium, isoraunescine and yohimbine on the noradrenaline depleting action of reseprine.

Authors:  N T KARKI; M K PAASONEN; P A VANHAKARTANO
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1959
  9 in total
  6 in total

Review 1.  Modeling and imaging cardiac sympathetic neurodegeneration in Parkinson's disease.

Authors:  Valerie Joers; Marina E Emborg
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-03-20

2.  Direct and indirect actions of dopamine on tracheal smooth muscle.

Authors:  Y Koga; H Downes; S M Taylor
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980       Impact factor: 3.000

3.  Intra-neuronal vesicular uptake of catecholamines is decreased in patients with Lewy body diseases.

Authors:  David S Goldstein; Courtney Holmes; Irwin J Kopin; Yehonatan Sharabi
Journal:  J Clin Invest       Date:  2011-07-25       Impact factor: 14.808

4.  The thermogenic actions of alpha 2-adrenoceptor agonists in reserpinized mice are mediated via a central postsynaptic alpha 2-adrenoceptor mechanism.

Authors:  D J Bill; I E Hughes; R J Stephens
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

5.  A pharmacological analysis of receptors mediating the excitatory response to 5-hydroxytryptamine in the guinea-pig isolated trachea.

Authors:  A Lucchelli; M G Santagostino-Barbone; A Barbieri; M Tonini
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

6.  Biochemical evidence for re-use of noradrenergic storage vesicles in the guinea-pig heart.

Authors:  A R Wakade; T D Wakade
Journal:  J Physiol       Date:  1982-06       Impact factor: 5.182

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.